Institutional investors purchased a net $2.9 million shares of BIOC during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 14.57% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 774.1 Thousand shares of Biocept Inc
BLACKROCK FUND ADVISORS Bought 687.3 Thousand shares of Biocept Inc
FRIGATE VENTURES LP Bought 652.4 Thousand shares of Biocept Inc